logo-loader
viewSativa Group PLC

Professor Page KCL to Medical Advisory Board

/**/ h2{margin-top:12.0pt;margin-right:0cm;margin-bottom:3.0pt;margin-left:0cm;font-size:14.0pt;font-family:"Calibri Light","sans-serif";color:windowtext;font-weight:bold;font-div:italic;}p{margin-right:0cm;margin-left:0cm;font-size:9.0pt;font-family:"Times New Roman","serif";color:black;}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: #954F72 } .dj{size:595.5pt 841.75pt;margin:45.35pt 72.0pt 45.35pt 72.0pt;}div.dj{}table.er{width:460.7pt;margin-left:-5.4pt;border-collapse:collapse}tr.ei{height:69.85pt}td.em{width:214.45pt;padding:0cm 5.4pt 0cm 5.4pt; height:69.85pt}p.es{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Cambria","serif";color:black;border:none;font-weight: bold}span.ep{font-size:11.0pt;font-family:"Calibri","sans-serif"}p.de,li.de,div.de{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Cambria","serif";color:black;border:none;}span.en{font-family:"Calibri","sans-serif"}td.ej{width:224.65pt;padding:0cm 5.4pt 0cm 5.4pt; height:69.85pt} p.et{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Cambria","serif";color:black;border:none;font-weight: bold; text-align: right}span.el{font-size:11.0pt;font-family:"Calibri","sans-serif";color:windowtext}p.dd,li.dd,div.dd{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;}p.eu{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;font-weight: bold; text-align: center}p.ev{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";color:windowtext;text-align:justify}span.ef{font-size:12.0pt}p.a,li.a,div.a{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:windowtext;}span.ew{font-family:"Calibri","sans-serif";color:black;border:none}span.ex{font-family: "Calibri","sans-serif"}table.ey{margin-left:6.8pt;border-collapse:collapse;border:none} tr.dw{height:61.0pt}td.dz{width:187.15pt;border:solid windowtext 1.0pt; padding:4.0pt 17.55pt 4.0pt 4.0pt;height:61.0pt}p.ez{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;margin-right:13.55pt;text-align:justify}span.ea{font-family:"Calibri","sans-serif";color:#070036; background:white}span.ec{font-family: "Calibri","sans-serif"}td.dx{width:216.0pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:61.0pt}p.fa{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;margin-right:12.95pt;text-align:justify}span.fb{font-family:"Calibri","sans-serif"}span.fc{font-family:"Calibri","sans-serif";color:#070036; background:white}span.dh{font-family:"Calibri","sans-serif";color:blue;text-decoration:underline;} td.du{width:187.15pt;border:solid windowtext 1.0pt; border-top:none;padding:4.0pt 17.55pt 4.0pt 4.0pt;height:61.0pt}span.fd{font-family: "Calibri","sans-serif"; font-weight: bold}td.dt{width:216.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:61.0pt}p.fe{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;font-weight: bold; margin-right: 13.55pt; text-align: justify}p.ff{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;margin-right:12.95pt;text-align:justify;border:none}p.fg{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:windowtext;margin-top:13.2pt;margin-right:0cm;margin-bottom: 13.2pt;margin-left:0cm;text-align:justify}span.dp{font-family:"Calibri","sans-serif"; color:black;background:#F4F4F4}span.dn{font-family:"Calibri","sans-serif";background:#F4F4F4}p.fh{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%;text-autospace:ideograph-other;font-size:11.0pt;font-family:"Calibri","sans-serif";color:windowtext;margin-left: 21.0pt; text-align: center; text-indent: -18.0pt}span.dl{font-size:12.0pt; line-height:115%;color:black;border:none} span.dm{background:#F4F4F4} /**/
RNS Number : 8857S
Sativa Group PLC
11 November 2019
 

Press Release 

 

11 November 2019

 

Sativa Group Plc

 

("Sativa" or "the Company" or "the Group") 

 

Professor Clive Page, OBE, BSc, PhD, FSoB, FBPhS,

Professor of Pharmacology at King's College London, appointed to Medical Advisory Board

 

Sativa Group Plc [NEX: SATI], the UK's leading quoted CBD wellness and medicinal cannabis Group, has appointed Clive Page, Professor of Pharmacology at King's College London, to its Medical Advisory Board.  Professor Page's main research interests are in the pharmacology of inflammation and respiratory disease, and he has published over 300 scientific papers and book chapters.  

 

He was awarded the Sandoz Prize from the British Pharmacological Society in 1988, The Tanabe Young Investigators Prize from the American College of Clinical Pharmacology in 1996 and the Society of Biology President's Medal in 2012 for "Outstanding Contributions to the Life Sciences".  He is a Fellow of the Royal Society of Biology and an Honorary Fellow of the British Pharmacological Society.  Professor Page was awarded an OBE for "Services to Pharmacology" in 2017.

 

Dr Nick Horniman, Director of Regulatory Affairs at Sativa, said:  "Professor Page is an eminent research scientist and will add to Sativa's experience, interest and understanding in cannabis based medical products." 

 

For further information please contact: 

 

Henry Lees-Buckley 

Chief Executive Officer

Sativa Group Plc 

+44 (0) 20 7971 1255

 

[email protected]

www.sativagroup.co.uk

Joseph Colliver

Chief Financial Officer

Sativa Group Plc 

+44 (0) 20 7971 1255

 

[email protected] 

www.sativagroup.co.uk

NEX Exchange Corporate Adviser

 

Corporate Finance 

 

Stephen Keys / Max Gould 

Cenkos Securities plc 

+44 (0) 20 7397 8900


Equity Sales 

 

Julian Morse

Cenkos Securities

+44 (0) 20 7397 8900


Financial PR and IR

 

Abchurch Communications

Julian Bosdet

+44 (0)207 4594 4070  

+44 (0) 7771 663 886 

 

 

[email protected]

www.abchurch-group.com

 

 

Notes to Editors. 

Sativa Group Plc is the UK's leading quoted CBD wellness and medicinal cannabis group with five operating subsidiaries. 

Goodbody Botanicals provides CBD products online and to retail markets including pharmacies, wellness stores and grocers.  Goodbody Wellness is a high-street retail brand with dedicated CBD wellness stores providing a premium shopping experience to consumers.  Tessellate Collective is a direct-selling network marketing platform servicing consumers at home.  Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses. 

 

Sativa Grow holds a Controlled Drug licence and cultivates cannabis plants to fulfil its partnership agreement with King's College London to research the impact of cannabinoids on inflammation and respiratory conditions. 

 

-     Ends -


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NEXURAARKVAAAUA

Quick facts: Sativa Group PLC

Price: 5.65

Market: NEX
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Sativa Group is setting up for the future after Home Office...

Sativa Group (LON: SATI) CEO Henry Lees-Buckley joined Steve Darling from Proactive Vancouver to discuss the UK’s first listed Cannabis Company. This company focussing on 4 key business areas. Lee-Buckley talking about those areas and why he feels the UK is the right place at the right time...

on 5/11/19